Penumbra is a medical technology company that develops and markets innovative medical devices for the diagnosis and treatment of various neurological and vascular diseases.
Founded in 2004 by a group of experienced engineers and physicians
The company went public in 2015 and is listed on the NYSE under the ticker symbol 'PEN'
Acquired companies like Neuravi, Inc. and MVI Health Inc. to expand product portfolio
A global medical technology company with a wide range of products for various medical fields, including neurovascular devices.
Develops and markets medical devices in various fields, including neurosurgery, cardiology, and orthopedics.
A multinational corporation that produces a range of medical devices and pharmaceuticals, including neurovascular devices.
A mechanical thrombectomy system used for the removal of blood clots in the brain caused by stroke.
A range of catheters used to access and navigate the brain's blood vessels during diagnostic and therapeutic procedures.
A detachable coil system used for the embolization of brain aneurysms, a procedure to prevent rupture and bleeding.
The Penumbra System is used for the removal of blood clots in the brain caused by stroke.
Yes, the Penumbra System is FDA-approved for the treatment of stroke caused by blood clots.
Mechanical thrombectomy is a minimally invasive procedure to remove blood clots in the brain using a catheter-based device, such as the Penumbra System.
The length of the Penumbra System procedure depends on the size and location of the blood clot, but it typically takes about one to two hours.
As with any medical procedure, there are risks and potential side effects associated with Penumbra System treatment, such as bleeding, infection, and allergic reaction to contrast material. However, these risks are generally low, and the benefits of the treatment typically outweigh the risks.